FDA authorizes COVID-19 vaccines as booster dose for kids ages 5-11
On Wednesday, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations of the Moderna and Pfizer COVID-19 bivalent vaccines to authorize their use as a single booster dose in younger age groups.